BioSpace News Archive

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a license agreement relating to its preclinical asset, Nepicastat, with Asieris Pharmaceuticals, a biotechnology company headquartered in China.

Moderna, Inc today announced it will host its in-person and virtual R&D Day at 9:00 a.m. ET on Thursday, September 8, 2022.

Kymera Therapeutics, Inc. will participate in Fireside Chats at the following upcoming investor conferences.

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Francesco Bibbiani, M.D., as senior vice president, head of development.

Reneo Pharmaceuticals, Inc. announced two poster presentations at the International Network for Fatty Acid Oxidation Research and Management (INFORM) annual meeting, being held in Freiburg, Germany August 28-29, 2022.

RedCloud Bio (the “Company”), an innovative biotech company integrating structural pharmacology and computational approaches to advance small molecule drug discovery and development, announced completion of the first patient dosing for its next-generation EGFR TKI H002 in its H002-101CN study.

Centessa Pharmaceuticals plc today announced that members of its management team will participate in the following investor conferences.

Timber Pharmaceuticals, Inc. today announced that seven abstracts detailing positive clinical data from the completed Phase 2b CONTROL study of TMB-001 were accepted for e-poster presentation at the 31st European Academy of Dermatology and Venerology (EADV) Congress, which will be held in Milan, Italy and virtually from September 7-10, 2022.

Enlivex Therapeutics Ltd. today announced that the Japanese Patent Office issued a Notice of Allowance for patent application number 2020-198242.

Cardiff Oncology, Inc. today announced that it will host a webcast and conference call to provide a clinical and corporate update on Monday, September 12, 2022.